EQUASHIELD® has been recognized as the most utilized closed system transfer device in the U.S. for the eighth consecutive year, holding a significant market share.

EQUASHIELD® is stepping up its sustainability efforts by moving to electronic Instructions for Use (eIFU), a major milestone for Earth Day 2026.

EQUASHIELD® is set to reveal its innovative safety platform at ASHP Midyear 2025 in Las Vegas, combining advanced technology to enhance healthcare safety and efficiency.

EQUASHIELD® has launched the innovative CellSHIELD®, a device that transforms cell and gene therapy manufacturing with enhanced safety and efficiency.

EQUASHIELD® celebrates its seventh consecutive year as the leading Closed System Transfer Device in US pharmacies, showcasing its commitment to safety and innovation in healthcare.

New PP&P State of Pharmacy Compounding report shows EQUASHIELD® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare environment where safety, consistency, and staff protection are non‑negotiable,...

PORT WASHINGTON, N.Y., April 22, 2026 /PRNewswire/ -- In recognition of Earth Day 2026, EQUASHIELD®, a global leader in hazardous drug handling, today announced its transition to electronic Instructions for Use (eIFU), a major milestone in the company's ongoing commitment to environmental...

PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD®, a global leader in Closed System Transfer Devices (CSTD) and pharmacy automation, will highlight its fully integrated hazardous drug safety and automated compounding platform at the ASHP Midyear Clinical Meeting & Exhibition...

PORT WASHINGTON, N.Y., Sept. 4, 2025 /PRNewswire/ -- EQUASHIELD®, a global leader in healthcare innovation, proudly announces the launch of CellSHIELD®, a groundbreaking device designed to transform cell and gene therapy manufacturing. Building on its proven expertise in CSTD technology,...

PORT WASHINGTON, N.Y., May 22, 2025 /PRNewswire/ -- EQUASHIELD®, a global leader in Closed System Transfer Devices (CSTDs) and automated compounding solutions, proudly announces that it has been ranked as the #1 CSTD used in US pharmacies for the seventh consecutive year by Pharmacy...